PAPER Veshohilova TP
SEARCH RESULTS
329939 RESULTS
PAPER Fecto F, Siddique T
Making connections: pathology and genetics link amyotrophic lateral sclerosis with frontotemporal lobe dementia.
J Mol Neurosci. 2011 Nov;45(3):663-75. PubMed: 21901496PAPER Peng C, Aron L, Klein R, Li M, Wurst W, Prakash N, Le W
Pitx3 is a critical mediator of GDNF-induced BDNF expression in nigrostriatal dopaminergic neurons.
J Neurosci. 2011 Sep 7;31(36):12802-15. PubMed: 21900559PAPER Arimoto T, Choi DY, Lu X, Liu M, Nguyen XV, Zheng N, Stewart CA, Kim HC, Bing G
Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra.
Neurobiol Aging. 2007 Jun;28(6):894-906. PubMed: 21887889PAPER Witlox J, Kalisvaart KJ, de Jonghe JF, Verwey NA, van Stijn MF, Houdijk AP, Traast HS, Maclullich AM, Van Gool WA, Eikelenboom P
Cerebrospinal fluid β-amyloid and tau are not associated with risk of delirium: a prospective cohort study in older adults with hip fracture.
J Am Geriatr Soc. 2011 Jul;59(7):1260-7. PubMed: 21718268PAPER Hashimoto M, Ikeda M
[Dementia:progress in diagnosis and treatment; Topics, I. Basic knowledge of dementia and pathophysiology; 2. Non-Alzheimer's disease associated disorders].
Nihon Naika Gakkai Zasshi. 2011 Aug 10;100(8):2099-108. PubMed: 21899140PAPER Tokuda T
[Dementia: progress in diagnosis and treatment; Topics; V. Recent topics; 1. Biomarkers for Alzheimer's disease and other dementia].
Nihon Naika Gakkai Zasshi. 2011 Aug 10;100(8):2177-86. PubMed: 21899149PAPER De Matteis MA, Luini A
Mendelian disorders of membrane trafficking.
N Engl J Med. 2011 Sep 8;365(10):927-38. PubMed: 21899453PAPER Ly PT, Song W
Loss of activated CaMKII at the synapse underlies Alzheimer's disease memory loss.
J Neurochem. 2011 Nov;119(4):673-5. PubMed: 21899538PAPER Vázquez-Higuera JL, Mateo I, Sánchez-Juan P, Rodríguez-Rodríguez E, Pozueta A, Calero M, Dobato JL, Frank-García A, Valdivieso F, Berciano J, Bullido MJ, Combarros O
Genetic variation in the tau protein phosphatase-2A pathway is not associated with Alzheimer's disease risk.
BMC Res Notes. 2011;4:327. PubMed: 21899770PAPER Kyrkanides S, Tallents RH, Miller JN, Olschowka ME, Johnson R, Yang M, Olschowka JA, Brouxhon SM, O'Banion MK
Osteoarthritis accelerates and exacerbates Alzheimer's disease pathology in mice.
J Neuroinflammation. 2011;8:112. PubMed: 21899735PAPER Alexandru A, Jagla W, Graubner S, Becker A, Bäuscher C, Kohlmann S, Sedlmeier R, Raber KA, Cynis H, Rönicke R, Reymann KG, Petrasch-Parwez E, Hartlage-Rübsamen M, Waniek A, Rossner S, Schilling S, Osmand AP, Demuth HU, von Hörsten S
Selective hippocampal neurodegeneration in transgenic mice expressing small amounts of truncated Aβ is induced by pyroglutamate-Aβ formation.
J Neurosci. 2011 Sep 7;31(36):12790-801. PubMed: 21900558PAPER Devi L, Ohno M
7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease.
Neuropsychopharmacology. 2012 Jan;37(2):434-44. Epub 2011 Sep 7 PubMed: 21900882PAPER Selkoe DJ
Resolving controversies on the path to Alzheimer's therapeutics.
Nat Med. 2011 Sep;17(9):1060-5. PubMed: 21900936PAPER Johnson RD, Schauerte JA, Wisser KC, Gafni A, Steel DG
Direct observation of single amyloid-β(1-40) oligomers on live cells: binding and growth at physiological concentrations.
PLoS One. 2011;6(8):e23970. PubMed: 21901146Current Filters
No filters selected